Daily Stock List
Auxilio, Inc. (AUXO)
SmallCapVoice and Wall Street Resources reported recently on Auxilio, Inc. (AUXO), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Auxilio, Inc. is the nation’s foremost Managed Print Services (MPS) Company exclusively serving the health care industry. It serves a national portfolio of almost 220 hospital campuses. Auxilio manages more than 1.5 billion documents yearly from more than 90,000 devices supporting over 280,000 caregivers. Auxilio has its corporate head office in Mission Viejo, California, and the Company lists on the OTCQB.
Auxilio received the 2011 and 2012 Managed Print Services Association Leadership Award for its “strategic creativity and operational excellence” in its delivery of document production and process management, solutions and savings for its customers. The Company is also a leading provider of IT Security Consulting for the healthcare industry.
Auxilio’s responsibilities for healthcare customers’ includes the onsite print environment. Hospitals and health systems benefit from infrastructure and process improvements that immediately lessen the cost of print/digital systems, provide sustainable increases in employee productivity, and enables hospital staff to better focus on providing patient care.
The Company also provides a wide variety of healthcare Information Technology (IT) advisory and professional services. Auxilio’s business model is vendor neutral, provides full-time, on-site customer service and technical experts. Its business model is also exclusive to the healthcare industry.
At the end of March, Auxilio announced the signing of a definitive acquisition agreement with Redspin, Inc. Redspin is integrated into Auxilio's Security Solutions Group. Redspin, is a top provider of HIPAA security risk assessments and penetration testing services. Carpinteria, California-headquartered Redspin is a trusted advisor to the healthcare industry. Auxilio acquired Redspin, Inc. on April 7, 2015. This is to complement its end-to-end enterprise wide Healthcare IT Security offering.
Last week, Auxilio announced financial results for Q2 ended June 30, 2015. Quarterly revenues grew 50.5 percent to a record $15.6 million. The Company produced $0.5 million of cash flows from operations during the first six months of 2015. It ended June 30, 2015, with $5.1 million in cash and cash equivalents.
Auxilio, Inc. (AUXO), closed Monday's trading session at $1.05, up 2.94%, on 120,969 volume with 49 trades. The average volume for the last 60 days is 10,255 and the stock's 52-week low/high is $0.81/$1.26.
Lexaria Corp. (LXRP)
PennyPickAlerts, PennyStocks24, MassiveStockProfits, Penny Stock Circle, 1-2-3 Stock Alerts, Jet-Life Penny Stocks, Equity Observer, and Shiznit Stocks reported earlier on Lexaria Corp. (LXRP), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Lexaria Corp. is a food sciences company focused on the delivery of cannabinoid compounds obtained from legal, agricultural hemp, through gourmet foods based upon its proprietary infusion technologies. Most of what the Company does currently is research and formulate food products that contain cannabidiol using an inventive, proprietary technology.
Lexaria concentrates on the delivery of active compounds, which can behave as superfoods via its proprietary infusion technologies. Its technology enables higher bioavailability rates for CBD; THC; NSAIDs; Nicotine and other molecules than is possible without lipophilic enhancement technology. This can allow for lower overall dosing requirements and/or higher effectiveness in active molecule delivery.
Lexaria has made significant gains in developing and implementing certain technologies related to the patent pending methods designed to improve bioavailability of certain molecules. This includes the aforementioned CBD and THC. Lexaria has now included in its patent pendings, applications for lipophilic delivery of Nicotine, NSAIDs, and certain vitamins.
Cannabinoids are a class of compounds found in several species of plants, like some Echinacea species, and more plentifully, in agricultural (or industrial) hemp where cannabidiol (CBD) can consist of 35 percent or more of the plant’s extracts.
Lexaria is active in two market segments, all focused on one’s comfort and well-being. It produces and sells edible consumer products infused with cannabidiol and available for sale in all 50 States. It also owns two patents pending for the infusion of CDBs within lipids. It is now investigating methods of expanding its intellectual property (IP) in this new field of research.
Lexaria has two distinctive consumer product brands. These are ViPova™ and Lexaria Energy. Both brands use patent pending technology to infuse cannabidiol within lipids in popular foods. The Company has a patent pending method through which it infuses its organically sourced high purity CBD-oil inside the molecules of other ingredients.
Lexaria introduced ViPova™ black tea infused with CBD in January of this year. This is a Chinese black tea from the province of Yunnan. It is CBD-infused within dried evaporated non-fat milk. Lexaria Energy products use the Company’s patent pending technology to efficiently deliver CBD in nutritious and appetizing formulations. Through its Lexaria Energy brand, the Company has its Lexaria Energy Bar. This is a CBD-infused protein bar.
Today, Lexaria announced what it believes is potential industry-changing achievements in enhanced gastro-intestinal absorption of cannabidiol (CBD) using its patent pending technology. The recent third-party testing was conducted in two phases of in vitro tests commencing in June and completed this month. The independent laboratory results have delivered average CBD permeability of 499 percent of baseline permeability, versus CBD permeability without the Company’s technology. These results exceed Lexaria’s expectations.
Lexaria Corp. (LXRP), closed Monday's trading session at $0.2145, up 25.44%, on 549,219 volume with 158 trades. The average volume for the last 60 days is 118,115 and the stock's 52-week low/high is $0.04/$0.2699.
Virtus Oil and Gas Corp. (VOIL)
Wyatt Investment Research, Market Authority, Investopedia, Investors Alley, SmallCap Fortunes, Flagler Financial Group, PennyStocks24, TheStockAdvisor, Trade of the Week, and FutureMoneyTrends.com reported previously on Virtus Oil and Gas Corp. (VOIL), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Virtus Oil and Gas Corp.’s goal is acquiring and developing onshore oil and gas working interests (WI’s) in proven basins in the U.S. It is presently exploring prospects in the state of Utah, specifically in the Central Utah Thrust Belt Region. Its ultimate strategic focus is the development of oil and natural gas production and reserves. Houston, Texas-based Virtus is tagging lease acquisitions in shallower and less developed areas within close proximity to drilling and production activity. Assets in the states of Louisiana and Texas are also undergoing consideration.
Vitus’ strategy is to acquire oil and gas properties that give it a majority working interest (WI) and operational control; utilize a highly experienced team of geologists, engineers, and Landmen; and remain focused on prolific hydrocarbon basins in North America
It earlier acquired the Parowan property. This property consists of acreage in southwestern Utah. The prospect is roughly 80 miles south of Wolverine Gas and Oil’s Covenant Oil Field, also positioned in the Central Utah Overthrust (CUO) area. Additionally, Virtus is looking for projects in the major North American shale plays. The Parowan Project is a prospect targeting the Central Utah Thrust Belt.
Virtus entered into an agreement in 2014 with an undisclosed seller to acquire an additional 18,000 acres in Iron County, Utah. This transaction expands its footprint to 55,477 acres centered on the Parowan Prospect, in the CUO region of southwestern Utah.
The Company announced in November 2014 that an updated independent assessment of its prospective resources by Gustavson Associates showed a 58.2 percent increase to Virtus’ best estimate of unrisked P50 recoverable resources on the Parowan Project. The evaluation report received in November 2014 is an update to the original April 10, 2014 version to reflect Virtus’ additional acquired acreage and mineral leases that were acquired on May 6, 2014.
Recently, Virtus Oil and Gas announced that a drilling contract was signed with Energy Drilling LLC to drill the Virtus Lone Pine 34-11-5 Well. Downhole tests and geologic findings gathered from the Virtus Lone Pine 34-11-5 Well will be used in combination with Virtus’ existing seismic resources to allay dry hole risk for the second well planned for the next calendar year. The second planned well will be drilled to a depth of roughly 12,000 feet to test additional zones.
Today, Virtus Oil and Gas announced that Utah's Bureau of Land Management (BLM) approved the Company’s permit to drill the Lone Pine 34-11-5 initial test well in Southern Utah. The Lone Pine well will be drilled to a total vertical depth of 7,000 feet this month. Drilling will take around five to seven days. An additional 12 to 15 days will be needed to complete the initial test well after drilling operations have been concluded. Virtus’ plan is to spud the well on August 25th, 2015.
Virtus Oil and Gas Corp. (VOIL), closed Monday's trading session at $0.28, up 47.29%, on 554,504 volume with 190 trades. The average volume for the last 60 days is 66,169 and the stock's 52-week low/high is $0.1706/$2.24.
Medbox, Inc. (MDBX)
Money Morning reported this month on Medbox, Inc. (MDBX), SmallCapVoice, The Street, and StreetInsider did earlier, and we highlight the Company today, here at the QualityStocks Daily Newsletter.
OTCQB-listed Medbox, Inc. provides specialized consulting services to the legal marijuana industry. The Los Angeles, California-headquartered Company also sells associated patented products. These include its Medbox medical dispensing system and medical vaporization devices. It also has its wholly-owned subsidiary, Vaporfection International, Inc. Via this subsidiary, it provides an industry award-winning medical line of vaporizer products.
Medbox is a foremost dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry. The Company provides its patented systems, software and consulting services to pharmacies, alternative medicine dispensaries, as well as local governments in the United States.
The Company uses its expertise to work with investors and entrepreneurs who look to enter the cannabis sector. It provides them with a high quality, turn-key solution, comprising licensing, site selection, permitting, design, and full build-out. Medbox has become a leader in providing compliance, safety, security, oversight and operational expertise to the medical and recreational cannabis industry nationwide.
Medbox is also developing supplementary services customized to the alternative medicine industry. These include real estate acquisitions and subsequent lease programs to alternative medicine dispensaries and cultivation centers, and alternative medicine dispensary and cultivation management services. The Company also engages in merchant services and armored transport for cash deposits - ancillary services catered to the alternative medicine industry.
Medbox features patented systems that dispense medication based on biometric identification (fingerprint sample). Its systems enable pharmacies, assisted living facilities, prisons, hospitals, doctors’ offices, and alternative medicine clinics to help manage employee possession of sensitive drugs. In a retail environment characteristic in most alternative medicine clinics, the system lets the clinics document that the user is a registered patient and that the patient has a valid and unexpired authorization from a physician to possess and use the medicine dispensed.
Medbox has its patented “Medbox”. The biometrically sealed inventory control, storage and dispensing technology ensures safe and secure access to marijuana in medical and recreational dispensaries.
Medbox’s Vaporfection has signed an exclusive North American distribution agreement for its "miVape" vaporizer with VaporNation. The miVape vaporizer is a self-contained, USB-rechargeable unit, which uses medical grade, food-safe and heat resistant materials to deliver the healthiest experience possible. VaporNation is the largest wholesaler and online retailer of vaporizers.
Last week, Medbox announced it engaged an experienced Israel-based medical marijuana consultancy. This is as Medbox prepares to enter the cultivation market and work with licensed independent growers.
Mr. Jeff Goh, President and interim CEO of Medbox, said, "We are aligning ourselves with world class experts, as we enter a new phase in our company's development. It is critical that products produced on our property by licensed independent growers be of the highest pharmaceutical quality to ensure efficacy and consistency for patients, as well as to drive sustainable revenues."
Medbox, Inc. (MDBX), closed Monday's trading session at $0.054, up 3.85%, on 4,629,206 volume with 273 trades. The average volume for the last 60 days is 1,939,363 and the stock's 52-week low/high is $0.05/$15.20.
Avra, Inc. (AVRN)
Greenbackers, Money Morning, TopStockAnalysts, Investors Alley, Insider Wealth Alert, Investopedia and Wyatt Investment Research reported on Avra, Inc. (AVRN), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Avra, Inc. consists of a team of Bitcoin enthusiasts, technocrats, financiers and international business experts. Bitcoin is a consensus network. It enables a new payment system and a completely digital money. Avra provides a range of solutions and services that make Bitcoin acceptance easy for any business. The Company provides the software, the point-of-purchase terminals, the education, and continuing payment systems. Avra lists on the OTC Bulletin Board.
Bitcoin is the first decentralized peer-to-peer payment network. It is powered by its users with no central authority or middlemen. Using Avra’s technology, most every internet connected point-of-sale (POS) system and ATM kiosk can be integrated to accept Bitcoin and related emerging digital currencies.
The Company’s business model is divided into five distinct categories. One is AvraPay: to develop a complete, turn-key and trouble-free way for merchants to accept Bitcoin as Payment. Additionally, AvraPay operates as a regionalized payment solution. Anyone wanting to pay their household bills, purchase top-ups, and more, can do so from the AvraPay portal using their digital wallet.
The second category is AvraATM: to promote usage and acceptance of digital currencies via Avra’s proposed network of ATMs. This is the Company’s Digital Currency integration for ATM Kiosk networks. Businesses can add a continuous stream of passive income to their kiosk business through installing AvraATM systems.
The third category is AvraTravel: to provide cryptocurrency payment processing solutions for merchants. This includes hotels and casinos. Avra provides hardware, software, education and ongoing support. Its specialty is working with hotels, casinos, and restaurants to leverage Bitcoin’s numerous benefits for a business and its customers.
The fourth division is AvraNews: to provide a news site emphasizing digital currency news. AvraNews provides live reporting and in-depth analysis, legal opinions, live charts, and related industry reports.
The Company also has its fifth division, AvraSecure. AvraSecure is suited to complement all forms of technical payment infrastructure. This includes Bitcoin ATM machines, electronic wallets and related digital storage and transaction systems, and also payment gateways for Visa® and MasterCard® processing.
AvraSecure provides a comprehensive range of hosting, server security, as well as management services. These provide fully-managed and co-managed security solutions to meet the security and infrastructure needs of an organization. AvraSecure is a dedicated platform, which provides vital security solutions to the emergent digital currency industry.
Avra, Inc. (AVRN), closed Monday's trading session at $0.235, up 23.68%, on 3,185,245 volume with 483 trades. The average volume for the last 60 days is 100,579 and the stock's 52-week low/high is $0.10/$1.26.
Giggles N' Hugs, Inc. (GIGL)
The QualityStocks Daily Newsletter would like to spotlight Giggles N' Hugs, Inc. (GIGL). Today, Giggles N' Hugs, Inc. closed trading at $0.20955, up 2.17%, on 31,400 volume with 17 trades. The stock’s average daily volume over the past 60 days is 27,054, and its 52-week low/high is $0.101/$0.64.
Los Angeles-based Giggles N' Hugs, Inc. (GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic gourmet food with the play elements for children in a 2500-square-foot play space in the middle of the restaurant. The concept is similar to Chuck E. Cheese, but offers a unique healthier, high-end version for health conscious parents and families. Parents eat and relax while the kids have an incredible time playing in the custom-made play area with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.
In addition to nightly shows and concerts, every 30 minutes Giggles N' Hugs provides an activity such as face painting, disco dance parties, karaoke, games, arts and crafts, and much more. Giggles N' Hugs has been voted the No. 1 family restaurant, No. 1 birthday party place, and the No. 1 indoor play space in all of Los Angeles, and has attracted a star-studded list of customers including Sandra Bullock, Heidi Klum, Jessica Alba, Halle Berry, Jennifer Garner and Ben Affleck, Denis Quaid, Mark Whalberg, Adam Sandler, Dustin Hoffman and many more.
Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40%), admission and membership fees to play, along with retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in the top premier malls around Los Angeles; four of the largest mall owners in the country are giving Giggles N' Hugs up to 75% discounts on rent and providing upward of $700,000 of upfront cash for each location to get Giggles N' Hugs into their malls around the country.
Growth and recognition of this caliber are driven by a very powerful management team. Giggles N' Hugs President John Kaufman was the COO at California Pizza Kitchen when the founders had just two locations. Joined by Giggles N' Hugs' CFO Phillip Gay, who at the time was CFO of California Kitchen, Kaufman grew the company from two to more than 100 locations – at which time it was bought by Pepsi Co. Kaufman was recruited as president of Koo Koo Roo Chicken, one of the fastest growing fast-casual concepts on the west coast, while Gay joined Wolfgang Puck Restaurants group as CFO, eventually becoming the CEO.
Giggles N' Hugs was founded as a truly "kid friendly" establishment catered specifically to the size, interests, and nutrition needs of children. Since opening its first Giggles N' Hugs in 2009, the company has received a steady stream of interest from more than 300 interested parties looking to expand the concept – via franchise or master licenses – in the U.S. as well globally in countries such as Germany, England, Dubai, Russia, Colombia, Australia , Singapore, Turkey, among the many more. Disclaimer
Giggles N' Hugs, Inc. Company Blog
Giggles N' Hugs, Inc. News:
Giggles Ní Hugs Advances Negotiations with largest National Mall Owners
Interest in Giggles Ní Hugs Franchise Opportunities Continues to Grow
Giggles N' Hugs, Inc. (GIGL) CEO Featured in Exclusive QualityStocks Interview
International Stem Cell Corp. (ISCOD)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCOD). Today, International Stem Cell Corp. closed trading at $3.45, up 3.60%, on 13,550 volume with 28 trades. The stock’s average daily volume over the past 60 days is 20,278, and its 52-week low/high is $1.25/$18.15.
International Stem Cell Corp. (ISCOD) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces Record Net Income in Second Quarter 2015
International Stem Cell Corporation Announces 1:150 Reverse Stock Split
International Stem Cell Corporation to Present at International Society for Cellular Therapy Annual Meeting
MIT Holding (MITD)
The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.04, even for the day, on 67,303 volume with 1 trade. The stock’s average daily volume over the past 60 days is 6,799, and its 52-week low/high is $0.03/$0.20.
MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.
In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.
Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.
MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer
MIT Holding Company Blog
MIT Holding News:
MIT Holding Achieves Positive Net Income From Operations in 2014
MIT Holding (MITD) Launches New Website with Investor Relations Suite
MIT Holding, Inc. Names Tommy J. Duncan as President
Alternet Systems, Inc. (ALYI)
The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.0199, off by 0.50%, on 41,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 40,210, and its 52-week low/high is $0.006/$0.0751.
Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.
Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets
Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.
Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.
With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.
As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer
Alternet Systems, Inc. Company Blog
Alternet Systems, Inc. News:
Alternet Systems Appoints Fabio Alvino as CEO of Alternet Payment Solutions
Alternet Systems Advances Strategic Initiative to Become a Leading Global Digital Currency Exchange Through OneMarket
Alternet Systems Partners With Wildcard Consulting to Launch Bitcoin Debit Card
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.002, even for the day. The stock’s average daily volume over the past 60 days is 62,191, and its 52-week low/high is $0.0012/$0.008.
Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.
Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.
Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Signs License Agreement With NYG Holdings
Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited
Consorteum Holdings Launches New Mobile Results App for Popular Keno Game
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Alternet Systems, Inc. (ALYI) Appoints Fabio Alvino as CEO of Alternet Payment Solutions
- Aristocrat Group Corp. (ASCC) Sponsored Artist Curtis Braly Performs for His Largest Crowd Yet
- Cherubim Interests, Inc. (CHIT) Announces Engagement of QualityStocks Investor Relations Services
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Announces Details of Upcoming Conference Call
- Fastfunds Financial Corp. (FFFC) Provides Update On Tommy Chong Green Card
- Galenfeha, Inc. (GLFH) Products Offered by Leading Power and Automation Company
- Giggles N' Hugs, Inc. (GIGL) Advances Negotiations with largest National Mall Owners
- Growblox Sciences, Inc. (GBLX) is Making Big Moves in Anticipation of Opening Nevada Cultivation Facility
- International Stem Cell Corp. (ISCOD) Announces Record Net Income in Second Quarter 2015
- Latitude 360, Inc. (LATX) Announces Engagement of QualityStocks Investor Relations Services
- Loans4Less.com Inc. (LFLS) Enters into an Acquisition Agreement with 321LEND
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- On the Move Systems, Inc. (OMVS) Shared Economy Couriers Can Help Retailers Reduce Delivery Times to Nearly Zero
- QS Energy, Inc. (QSEP) Formerly Save the World Air, Inc., Announces New Corporate Identity and Updated Business Strategy
- Star Mountain Resources Inc. (SMRS) Pursues Acquisition Opportunities in North American Mining Sector
- View Systems, Inc. (VSYM) in Discussions With Three M&A Candidates and Reviewing Letter of Intent
- Well Power Inc. (WPWR) Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors
- WRIT Media Group, Inc. (WRIT) Featured in Exclusive QualityStocks Production Video